Biogen Inc. buy The Goldman Sachs Group, Inc.
Start price
23.04.25
/
50%
€103.95
Target price
23.04.26
€172.63
Performance (%)
54.44%
End price
24.04.26
€160.54
Summary
This prediction ended on 24.04.26 with a price of €160.54. With a performance of 54.44% the BUY prediction by The_Goldman_Sachs_Gr was a big success. The_Goldman_Sachs_Gr has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 2.372% | 2.372% | 54.860% |
| iShares Core DAX® | -1,28 % | 4,21 % | 7,08 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % | 26,18 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % | 44,32 % |
| iShares S&P 500 | -2,31 % | -0,10 % | 20,82 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $219.00 to $197.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten